Dosage & Half-Life Extension: Finding the Balance Between Dosage & Less Frequent Administration of Drugs
Time: 8:00 am
day: Pre-Conference Workshop Day - WORKSHOP B
Details:
Over the years, the focal point when developing drugs for the eye has been to achieve sustained release to reduce the frequency of drug administration for better patient care. The field has struggled with finding the ideal dose that doesn’t cause inflammation and is sustained within the eye for a prolonged period of time to decrease the frequency of injections.
Attend this workshop to learn how you can:
- Achieve slow-release and durable formulation drugs to avoid increasing dosage that could result in inflammation
- Understand the ideal dose to reduce the frequency of injections to one every 6-9 months for better patient
- Examine different routes of administration represent different dosage forms, therefore, it is crucial to understand the complexity of delivering to the eye i.e. testing the system, drug product, methodology, device
- Explore how to extend half-life of large molecule drugs to limit redosing via intravitreal injection, to once every 6-9 months, to reduce patient burden and concerns
